oncology – Medxy AI

Tangential Versus Segmental Portomesenteric Venous Resection in Pancreatic Cancer Surgery: Insights from a Global Cohort Study

By MedXY 10/31/2026

This international multicenter study shows no significant difference in surgical complications or survival between tangential and segmental portomesenteric venous resections during pancreatoduodenectomy for pancreatic cancer with limited vein involvement.

news OB/GYN & Women's Health Oncology

Disparities in Immunotherapy Use for Advanced Endometrial Cancer Among Older Adults: Insights from NCDB Analysis

By MedXY 10/27/2026

Immunotherapy use in older patients with advanced endometrial cancer has increased over recent years but remains lower among the oldest and racial minorities, highlighting persisting treatment disparities.

Hematology-Oncology news Oncology

You Are Already Trained for This: Harnessing Hematology-Oncology Expertise in Radiation Mass Casualty Management

By MedXY 10/01/2026

Hematologists and oncologists possess critical skills to address hematologic complications of acute radiation syndrome and are essential in bolstering mass casualty radiation response, utilizing existing resources and infrastructure for efficient patient care.

news OB/GYN & Women's Health Oncology

Advancing Sentinel Lymph Node Biopsy in Vulvar Cancer: Real-Time Near-Infrared Fluorescence Imaging Enhances Detection and Safety

By MedXY 09/25/2026

A recent study demonstrates the feasibility and safety of hybrid indocyanine green and technetium-99m nanoparticle fluorescence imaging for sentinel lymph node biopsy in early-stage vulvar cancer, improving detection rates and oncologic outcomes.

news OB/GYN & Women's Health Oncology

Pembrolizumab Plus Chemotherapy for Cervical Cancer: Five-Year Exploratory Analysis from the KEYNOTE-826 Randomized Clinical Trial

By MedXY 09/14/2026

Five-year data from KEYNOTE-826 confirm pembrolizumab combined with chemotherapy as a durable, first-line treatment improving survival in persistent, recurrent, or metastatic cervical cancer without new safety concerns.

Hematology-Oncology news Oncology

Cancer Biologics Utilization After Biosimilar Entry and Financial Implications For Payers and Patients

By MedXY 08/30/2026

This study examines the impact of biosimilar introduction on cancer biologics, highlighting reduced costs and market share for originator biologics, benefiting both payers and patients.

news Oncology Psychiatry

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer

By MedXY 06/10/2026

A large study of veterans with cancer found persistent risk of suicidal self-directed violence, especially in younger, unmarried, frail, or mentally ill patients and those with central nervous system, head and neck, or thyroid cancers.

news Oncology Ophthalmology

Immune Checkpoint Inhibitor-Associated Uveitis: Comparative Risk Across Cancers and Drug Classes

By MedXY 06/04/2026

A multicenter study found that immune checkpoint inhibitor–associated uveitis risk varies by cancer type and drug class, with melanoma showing the highest intrinsic risk and RCC risk largely linked to ipilimumab/nivolumab exposure.

Clinical Updates news

Beyond the Diagnosis: Addressing the Persistent Risk of Suicidal Self-Directed Violence in Veterans with Cancer

By MedXY 05/31/2026

This review synthesizes recent longitudinal evidence on suicidal self-directed violence (SSDV) among veterans with cancer, identifying high-risk subgroups, temporal vulnerability windows, and the critical need for long-term psychological surveillance in survivorship.

Clinical Updates news

Longitudinal Suicide Risk in Veterans with Cancer: A Comprehensive Synthesis of Risk Factors and Temporal Trends

By MedXY 05/31/2026

This review synthesizes longitudinal evidence on suicidal self-directed violence (SSDV) among veterans with cancer, identifying high-risk clinical subgroups, temporal peaks in vulnerability, and the critical need for long-term survivorship screening beyond fatal outcomes.

news Oncology Psychiatry

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer

By MedXY 05/31/2026

A national study of veterans with cancer found elevated suicide-related risk that persisted for years, especially among younger, unmarried, frail, or mentally ill patients and those with certain cancers such as central nervous system and thyroid tumors.

news Oncology Psychiatry

When Severe Mental Illness Meets Lung Cancer: Why Equal Treatment Still Isn’t Guaranteed

By MedXY 05/29/2026

A large Japanese study found that people with schizophrenia spectrum disorders were less likely to receive several standard treatments for non-small cell lung cancer, underscoring a persistent and preventable gap in cancer care.

Gastroenterology news Oncology

Adherence to Surveillance in the Watch and Wait Approach for Rectal Cancer

By MedXY 05/08/2026

Study finds 62% of rectal cancer patients on Watch and Wait receive optimal surveillance, with younger patients showing better adherence. Critical gaps occur in the first year, particularly in initial endoscopic/imaging exams and colonoscopies.

news Oncology Public Health

Survival of Patients Diagnosed With Cancer During the COVID-19 Pandemic

By MedXY 04/22/2026

A cohort study of over 1 million cancer patients revealed significant reductions in 1-year survival rates during 2020-2021 compared to pre-pandemic trends, with an estimated 17,390 excess cancer deaths attributable to pandemic-related care disruptions.

Diabetes & Endocrinology news Oncology

Three Modifiable Factors Predict Emotional Impairment in Thyroid Cancer Patients: What Clinicians Need to Know

By MedXY 04/13/2026

A prospective study identifies exhaustion, head and neck discomfort, and body image concerns as independent predictors of poor emotional functioning in differentiated thyroid carcinoma patients. These findings highlight actionable targets for prehabilitation and rehabilitation programs.

Clinical Updates news Oncology

Optimizing the Synergy: Sequential vs. Concurrent Radiotherapy and Immunotherapy in Advanced Non-Small Cell Lung Cancer

By MedXY 03/31/2026

This review evaluates the optimal sequencing of radiotherapy and immunotherapy in advanced NSCLC, highlighting real-world evidence from the OCEANUS study favoring sequential over concurrent administration.

Gastroenterology news Oncology

Spatial Profiling of Resistance Mechanisms in HER2-Positive Gastric Cancer: Insights from Patient-Matched Analysis

By MedXY 03/27/2026

This report examines spatial transcriptomic data from HER2+ gastric cancer patients to identify resistance mechanisms to trastuzumab and T-DXd, including EMT and ERAD pathway activation.

news Oncology Otorhinolaryngology

Liquid Biopsy Predicts Recurrence in HPV-Independent Head and Neck Cancer Months Before Imaging

By MedXY 03/23/2026

A prospective study demonstrates that tumor-informed ctDNA-based minimal residual disease (MRD) testing significantly predicts recurrence and survival in HPV-independent HNSCC, offering a median five-month lead time over clinical detection and standard imaging.

news Oncology

Exploring Diagnostic Delays for Gynecologic and Breast Cancers Following Emergency Department Visits

By MedXY 03/23/2026

This study analyzes how cancer diagnosis timing varies after an emergency department visit, finding that breast cancer faces the longest delays while ovarian cancer is often diagnosed immediately. Factors like comorbidities and primary care access significantly influence these diagnostic intervals.

$Head and Neck Metastases From Infraclavicular Primary Tumors: Analysis of 136 Cases$

news Oncology Otorhinolaryngology

Head and Neck Metastases From Infraclavicular Primary Tumors: Analysis of 136 Cases

By MedXY 03/18/2026

This clinical analysis of 136 patients highlights that head and neck metastases often serve as the primary manifestation of infraclavicular cancers, emphasizing the diagnostic value of cervical lymph nodes.